VESUGEN 20 MG

Vesugen 20 mg – Vascular Tissue Peptide Bioregulator | Peptide Hubs

Vesugen is a short-chain peptide bioregulator derived from vascular endothelial tissue, offered in a 20 mg (2 mL) vial by Peptide Hubs. It is used in research to study gene expression regulation in blood vessels, cellular repair of vascular endothelium, and cardiovascular aging. As a cytomolecular bioregulator, Vesugen targets vascular health at the genomic level, making it a promising compound for longevity, recovery, and cardiovascular protection protocols.

What Is Vesugen?

Vesugen belongs to the class of tissue-specific peptides known as cytomedines or bioregulators. It influences the function of endothelial cells, supporting vascular tone, elasticity, and repair. It is often studied in the context of hypertension, atherosclerosis, ischemia-reperfusion injury, and vascular degradation due to aging. According to research on peptide bioregulation, compounds like Vesugen may play a role in reversing endothelial senescence and supporting angiogenesis.

Key Research Applications

• Vascular endothelial repair and maintenance
• Support in cardiovascular aging models
• Improved elasticity and function of arterial walls
• Epigenetic regulation of blood vessel gene expression
• Research into stroke recovery, ischemia, and hypertension

Suggested Dosage in Research

Vesugen is typically dosed at 10–20 mg per week in preclinical trials. Administration is usually subcutaneous, split into multiple injections across a 2–4 week research protocol. This peptide is non-hormonal, does not affect androgen or estrogen pathways, and supports tissue-specific action without systemic overload.

Peptide Stack Recommendations

Researchers aiming to expand on vascular or anti-aging outcomes frequently stack Vesugen with:

• GHK-Cu – promotes angiogenesis, wound repair, and vascular elasticity
• BPC-157 – regenerative peptide that supports endothelial and arterial wall healing
• SS-31 – mitochondrial peptide for oxidative stress reduction in blood vessels
• Thymalin – supports immune-endocrine interaction and system-wide peptide regulation
• AOD 9604 – for metabolic and anti-aging synergy

Safety Profile

Vesugen has shown no toxicity in research studies and does not negatively impact hormonal, hepatic, or renal systems. It is not associated with blood pressure spikes or cardiac strain. The peptide acts locally at the vascular tissue level and is rapidly metabolized. This product is strictly for laboratory research use and is not approved for human or veterinary use.

USA Shipping & Quality Compliance

Peptide Hubs offers fast, secure USA domestic shipping on Vesugen 20 mg and all other research peptides. All products are manufactured in GMP-certified laboratories and tested for identity, purity, and sterility. Vesugen is an excellent candidate for vascular rejuvenation and anti-aging peptide research.

Frequently Asked Questions